Belgian centre rules on multibillion pharma fraud claim

A US pharmaceutical company says it has prevailed in what is thought to be the largest-ever case heard at Belgian arbitral institution CEPANI, concerning alleged fraud during a US$4.3 billion acquisition.


Get unlimited access to all Global Arbitration Review content